nitrendipine has been researched along with Aldosteronism in 2 studies
Nitrendipine: A calcium channel blocker with marked vasodilator action. It is an effective antihypertensive agent and differs from other calcium channel blockers in that it does not reduce glomerular filtration rate and is mildly natriuretic, rather than sodium retentive.
nitrendipine : A dihydropyridine that is 1,4-dihydropyridine substituted by methyl groups at positions 2 and 6, a 3-nitrophenyl group at position 4, a ethoxycarbonyl group at position 3 and a methoxycarbonyl group at position 5. It is a calcium-channel blocker used in the treatment of hypertension.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The chronic effect of the calcium antagonist nitrendipine was investigated on blood pressure (BP), plasma aldosterone concentration (PAC), plasma renin activity (PRA), and serum potassium in six patients with primary aldosteronism, either due to an (unilateral) aldosterone-producing adenoma (APA; n = 3; age, 44 +/- 4 years; PAC, 312 +/- 96 pg/ml; PRA, less than 0." | 5.06 | Therapeutic value of calcium antagonists in autonomous hyperaldosteronism. ( Ivens, K; Kaufmann, W; Stimpel, M; Volkmann, HP; Wambach, G, 1989) |
| "The chronic effect of the calcium antagonist nitrendipine, a 1,4-dihydropyridine derivative, on blood pressure (BP), plasma aldosterone concentration (PAC), plasma renin activity (PRA), and serum potassium was investigated in six patients with primary aldosteronism, either due to an (unilateral) aldosterone-producing adenoma (APA) (n = 3; age 44 +/- 4 years; PAC: 312 +/- 96 pg/ml; PRA: less than 0." | 3.67 | Are calcium antagonists helpful in the management of primary aldosteronism? ( Ivens, K; Kaufmann, W; Stimpel, M; Wambach, G, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stimpel, M | 2 |
| Ivens, K | 2 |
| Wambach, G | 2 |
| Kaufmann, W | 2 |
| Volkmann, HP | 1 |
1 trial available for nitrendipine and Aldosteronism
| Article | Year |
|---|---|
Therapeutic value of calcium antagonists in autonomous hyperaldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aldosterone; Blood Pressure; Clinical Trials as Topic; Fema | 1989 |
1 other study available for nitrendipine and Aldosteronism
| Article | Year |
|---|---|
Are calcium antagonists helpful in the management of primary aldosteronism?
Topics: Adult; Aging; Blood Pressure; Calcium Channel Blockers; Female; Humans; Hyperaldosteronism; Male; Mi | 1988 |